EPHB2 Promotes the Progression of Oral Squamous Cell Carcinoma Cells Through the Activation of VPS4A ‐Mediated Autophagy
Cancer Science · 2025
DOI: 10.1111/cas.70033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Yongchun Peng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Autophagy, Mouth Neoplasms, Receptor, EphB2, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The science and technology innovation Program of Hunan Province, National Natural Science Foundation of China, Natural Science Foundation of Hainan Province.
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) is a prevalent type of head and neck neoplasm distinguished by a high risk of metastasis and a poor prognosis. Nevertheless, the fundamental mechanisms of OSCC cell proliferation and metastasis remain poorly understood. Autophagy, as the principal intracellular degradation system, has been implicated in OSCC progression; however, its underlying mechanism remains unclear. In this study, transcriptomic sequencing analysis was performed using both The Cancer Genome Atlas (TCGA) database and samples from OSCC patients and revealed significant upregulation of EPHB2 expression, which is positively correlated with OSCC metastasis and a poor prognosis. In subsequent studies, we observed that the knockdown of EPHB2 resulted in the blockade of autophagic flux due to impaired lysosomal function, leading to inhibited proliferation, migration, and invasion in OSCC cells. Furthermore, the knockdown of EPHB2 significantly suppressed the expression of VPS4A, a key mediator that facilitates autolysosomal degradation. The overexpression of VPS4A restored lysosomal function and autophagic flux, thereby attenuating the inhibitory effects of EPHB2 knockdown on OSCC cell progression. The findings of this study demonstrate that the molecular mechanism underlying EPHB2 regulation of autophagic flux to promote OSCC progression is by regulating VPS4A activity and that EPHB2 may be a diagnostic biomarker and therapeutic target for OSCC prevention and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
- Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
ORCID-Profile: Sheng Zhang, Tengfei Fan
Förderung
- The science and technology innovation Program of Hunan Province
- National Natural Science Foundation of China
- Natural Science Foundation of Hainan Province
- Natural Science Foundation of Changsha
Zitieren
APA
Peng, Y., Zhang, J., Guo, H., He, Z., Jiang, Y., Zhang, S., & Fan, T. (2025). EPHB2 Promotes the Progression of Oral Squamous Cell Carcinoma Cells Through the Activation of VPS4A ‐Mediated Autophagy. Cancer Science. https://doi.org/10.1111/cas.70033
Vancouver
Peng Y, Zhang J, Guo H, He Z, Jiang Y, Zhang S, et al. EPHB2 Promotes the Progression of Oral Squamous Cell Carcinoma Cells Through the Activation of VPS4A ‐Mediated Autophagy. Cancer Science. 2025. doi:10.1111/cas.70033
BibTeX
@article{Peng2025,
author = {Peng, Yongchun and Zhang, Jianbo and Guo, Haoxuan and He, Zhijing and Jiang, Yi and Zhang, Sheng and Fan, Tengfei},
title = {EPHB2 Promotes the Progression of Oral Squamous Cell Carcinoma Cells Through the Activation of VPS4A ‐Mediated Autophagy},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.70033}
}
EUVIMED